Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -18.9040.1821.22112.252.74

What is the latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS is -18.90 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-18.90
Mar202340.18
Mar202221.22
Mar2021112.25
Mar20202.74

How is Core EBITDA Growth of JAGSONPAL PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 -18.9
Negative
Mar2023 40.18
89.35
Mar2022 21.22
-81.10
Mar2021 112.25
3,996.72
Mar2020 2.74 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,599.2 Cr -5.8% -1.6% 45.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,692.0 Cr -5.3% -7.8% 24.1% Stock Analytics
DIVIS LABORATORIES ₹149,215.0 Cr -3.9% -7.9% 51% Stock Analytics
CIPLA ₹115,000.0 Cr -1.9% -6.9% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,616.4 Cr -8.3% -14.9% 0.8% Stock Analytics
ZYDUS LIFESCIENCES ₹93,841.4 Cr -5.7% -4% 23.6% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

-5.8%

-1.6%

45.2%

SENSEX

0.2%

-2.2%

7.7%


You may also like the below Video Courses